Medication use in Poland for children and adolescents with neurodevelopmental disorders: before, during and after the COVID-19 pandemic – a retrospective pharmacoepidemiological study using national reimbursement data

CONCLUSION: The COVID-19 pandemic induced broad but temporary increases in pediatric psychotropic drug dispensing, except for ADHD pharmacotherapies, which demonstrated a persistent upward trend. These findings suggest lasting shifts in diagnostic and therapeutic practices and underscore the need for continued monitoring of stimulant use and prescribing appropriateness in pediatric neurodevelopmental care.

via https://pubmed.ncbi.nlm.nih.gov/41573735/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1L37KAMf2b_g4WEK3LmdFuKZu9pO3cN7u4ZmO9PPCPeBLMIw1q&fc=None&ff=20260202010905&v=2.18.0.post22+67771e2